
$4.8B+5% YoYFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Revenue reached $4.8B in 2025, compounding +7% a year since 2022 though the path has been bumpy. The trailing twelve months are already running at $5.2B, ahead of the last full year.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
$-632MFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→The company lost $632M in 2025, more than the $353M it lost the year before. The losses are widening - check the Health chapter for how long the cash lasts.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
+4.6%revenue growth, FY 2025
Off the axis: 2017 earnings -536.2% · 2019 earnings -235.4% - rebounds off a collapsed prior year.
→Revenue grew +5% in 2025 against a five-year average of +36%. 2017's swing into loss (-536%) and 2019's swing into loss (-235%) sits off the axis.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
$-366MFY 2025
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→The business consumed $366M of cash in 2025 after investment. Growth is being funded from the balance sheet, not from operations.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Free cash flow is negative, so no share of revenue is currently converting to spare cash. Every sales dollar is being reinvested or consumed.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→The biggest claim on each sales dollar is capital spending, at 5% of revenue (stock compensation 0%).
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→Operating profit outgrew revenue in only 1 of the last 5 years. Costs are growing roughly in step with the business, so scale isn't yet paying for itself.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→Operating margin widened 13 points to -0% since 2022. The bottom line is still negative: costs below the operating line eat what is left. AMC doesn't tag a gross-profit line in its filings, so the chart starts at operating margin.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
◌ 2026 = trailing twelve months to the latest filed quarter (2026-06-30), not a full fiscal year
→Return on capital needs both a profit and an equity base; one of them isn't available here.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
0.5xP/S today
→At 0.5x sales, the market is paying 87% less than AMC's own 11-year median of 3.6x. Pessimism is priced in - the question is whether it is deserved. Today's multiple is the lowest in the charted history.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
-0.9%FCF yield today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→Every dollar of market value currently buys -0.9% of annual free cash flow, less than its 11-year median of -2.7% - you are paying up for the same cash.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→Debt of $3.9B sits against $778M of cash. Earnings cover interest only 0.5 times, which is thin.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→Shareholders' equity is negative at $-1.5B: liabilities exceed assets. Usually the mark of heavy buybacks or accumulated losses, and always worth understanding which.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→Shareholders received $22M in buybacks and $700,000 in dividends in 2018. Stock compensation issued $17M of new shares in the same year, offsetting 75% of that.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→The share count grew 42.0% in 2025, averaging 66.9% a year over three years. Your slice of the company shrinks by that much each year unless earnings grow faster.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→The dividend per share reached $0.01 in 2022, compounding -62% a year since 2017.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→The dividend consumed 234% of profit and 138% of free cash flow in 2018. That is a thin cushion: a bad year would put the payment under real pressure.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→AMC's return on capital is negative at -0.3% in 2025. The capital in the business is not yet earning anything back.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→AMC issued +518% more shares from 2013 to 2025 and revenue per share still fell -71%. On this measure the new shares have not paid for themselves.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30
→Insiders bought $344,350 of stock on the open market and sold nothing. Buying with their own money is the one insider signal that is hard to explain away. A further 58 filings were grants, option exercises or tax withholding, which say nothing either way.
Source: SEC EDGAR (XBRL company facts) · as at 2026-06-30